Alexion Pharmaceuticals, Inc. financial reports, Alexion Pharmaceuticals, Inc. annual revenue in 2024. When does Alexion Pharmaceuticals, Inc. report revenue?
Alexion Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue Alexion Pharmaceuticals, Inc. is now 1 384 300 000 $. Information about net revenue is taken from open sources. Net income of Alexion Pharmaceuticals, Inc. today amounted to 889 000 000 $. The dynamics of Alexion Pharmaceuticals, Inc. net income rose by 421 400 000 $. The assessment of the dynamics of Alexion Pharmaceuticals, Inc. net income was made in comparison with the previous report. The financial report chart on our website displays information by dates from 30/06/2017 to 31/12/2019. Alexion Pharmaceuticals, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Alexion Pharmaceuticals, Inc. net income is shown in blue on the graph.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019
1 384 300 000 $
+22.63 % ↑
889 000 000 $
-
30/09/2019
1 263 100 000 $
+23.05 % ↑
467 600 000 $
+41.31 % ↑
30/06/2019
1 203 300 000 $
+15.15 % ↑
459 800 000 $
-
31/03/2019
1 140 400 000 $
+22.51 % ↑
587 900 000 $
+136.01 % ↑
31/12/2018
1 128 800 000 $
-
-45 000 000 $
-
30/09/2018
1 026 500 000 $
-
330 900 000 $
-
30/06/2018
1 045 000 000 $
-
-457 400 000 $
-
31/03/2018
930 900 000 $
-
249 100 000 $
-
31/12/2017
910 100 000 $
-
30 300 000 $
-
30/09/2017
859 000 000 $
-
78 000 000 $
-
30/06/2017
912 000 000 $
-
165 000 000 $
-
Show:
to
Alexion Pharmaceuticals, Inc. financial report charts
Dates of Alexion Pharmaceuticals, Inc. finance reports: 30/06/2017, 30/09/2019, 31/12/2019. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Alexion Pharmaceuticals, Inc. is available online for such a date - 31/12/2019. Gross profit Alexion Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Alexion Pharmaceuticals, Inc. is 1 270 000 000 $
Alexion Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Alexion Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Alexion Pharmaceuticals, Inc. is 114 300 000 $ Total revenue Alexion Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Alexion Pharmaceuticals, Inc. is 1 384 300 000 $ Operating revenue Alexion Pharmaceuticals, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Alexion Pharmaceuticals, Inc. is 1 384 300 000 $
Operating income Alexion Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Alexion Pharmaceuticals, Inc. is 545 500 000 $ Net income Alexion Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Alexion Pharmaceuticals, Inc. is 889 000 000 $ Current assets Alexion Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Alexion Pharmaceuticals, Inc. is 5 076 400 000 $
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 270 000 000 $
1 167 900 000 $
1 104 100 000 $
1 054 600 000 $
1 032 000 000 $
935 900 000 $
950 200 000 $
839 300 000 $
765 900 000 $
702 000 000 $
828 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
114 300 000 $
95 200 000 $
99 200 000 $
85 800 000 $
96 800 000 $
90 600 000 $
94 800 000 $
91 600 000 $
144 200 000 $
157 000 000 $
84 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 384 300 000 $
1 263 100 000 $
1 203 300 000 $
1 140 400 000 $
1 128 800 000 $
1 026 500 000 $
1 045 000 000 $
930 900 000 $
910 100 000 $
859 000 000 $
912 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
1 384 300 000 $
1 263 100 000 $
1 203 300 000 $
1 140 400 000 $
1 128 800 000 $
1 026 500 000 $
1 045 000 000 $
930 400 000 $
911 100 000 $
859 000 000 $
912 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
545 500 000 $
560 100 000 $
537 100 000 $
497 200 000 $
429 100 000 $
430 300 000 $
425 900 000 $
325 600 000 $
124 000 000 $
156 000 000 $
284 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
889 000 000 $
467 600 000 $
459 800 000 $
587 900 000 $
-45 000 000 $
330 900 000 $
-457 400 000 $
249 100 000 $
30 300 000 $
78 000 000 $
165 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
269 600 000 $
232 900 000 $
187 600 000 $
195 900 000 $
205 600 000 $
174 800 000 $
173 400 000 $
176 600 000 $
265 400 000 $
195 000 000 $
199 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
838 800 000 $
703 000 000 $
666 200 000 $
643 200 000 $
699 700 000 $
596 200 000 $
619 100 000 $
513 700 000 $
641 900 000 $
546 000 000 $
544 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
5 076 400 000 $
4 341 200 000 $
4 168 500 000 $
3 650 600 000 $
3 385 000 000 $
3 248 400 000 $
2 836 100 000 $
3 152 000 000 $
2 953 900 000 $
2 882 000 000 $
2 789 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
17 544 600 000 $
14 815 000 000 $
14 567 700 000 $
13 999 600 000 $
13 931 900 000 $
13 843 600 000 $
13 490 400 000 $
13 830 200 000 $
13 583 300 000 $
13 643 000 000 $
13 489 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
2 685 500 000 $
2 171 300 000 $
1 984 200 000 $
1 544 800 000 $
1 365 500 000 $
1 228 900 000 $
727 500 000 $
513 700 000 $
584 400 000 $
550 000 000 $
542 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
1 194 300 000 $
1 091 200 000 $
1 031 500 000 $
943 800 000 $
1 174 000 000 $
1 027 400 000 $
1 044 400 000 $
236 300 000 $
167 400 000 $
167 000 000 $
192 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
1 590 900 000 $
1 474 100 000 $
1 529 000 000 $
1 444 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
6 272 800 000 $
4 447 800 000 $
4 404 200 000 $
4 293 000 000 $
4 766 600 000 $
4 673 900 000 $
4 723 000 000 $
3 067 900 000 $
3 231 000 000 $
3 090 000 000 $
3 152 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
35.75 %
30.02 %
30.23 %
30.67 %
34.21 %
33.76 %
35.01 %
22.18 %
23.79 %
22.65 %
23.37 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
11 271 800 000 $
10 367 200 000 $
10 163 500 000 $
9 706 600 000 $
9 165 300 000 $
9 169 700 000 $
8 767 400 000 $
9 112 700 000 $
8 893 100 000 $
8 944 000 000 $
8 875 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
517 100 000 $
599 500 000 $
538 400 000 $
429 900 000 $
83 400 000 $
387 100 000 $
-343 800 000 $
299 300 000 $
257 600 000 $
270 000 000 $
280 100 000 $
Last revenue report of Alexion Pharmaceuticals, Inc. was 31/12/2019. According to last financial report total revenue in Alexion Pharmaceuticals, Inc. was 1 384 300 000 US dollar and changed by +22.63% since last year. Net income in Alexion Pharmaceuticals, Inc. was 889 000 000 $ in last quartal, net income changes to +41.31%.
Total assets Alexion Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Alexion Pharmaceuticals, Inc. is 17 544 600 000 $ Current cash Alexion Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Alexion Pharmaceuticals, Inc. is 2 685 500 000 $ Current debt Alexion Pharmaceuticals, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Alexion Pharmaceuticals, Inc. is 1 194 300 000 $
Alexion Pharmaceuticals, Inc. stocks data
ALXN stock price
Alexion Pharmaceuticals, Inc. stock price today, ALXN stock quote.
